CAS: 65002-17-7 - bucillamine

Fórmula: C₇H₁₃NO₃S₂

InChI: InChI=1S/C7H13NO3S2/c1-7(2,13)6(11)8-4(3-12)5(9)10/h4,12-13H,3H2,1-2H3,(H,8,11)(H,9,10)/t4-/m0/s1

Clave InChI: InChIKey=VUAFHZCUKUDDBC-BYPYZUCNSA-N

SMILES: O=C(O)C(NC(=O)C(S)(C)C)CS

Sinónimos:

• (2R)-2-(2-Methyl-2-sulfanylpropanamido)-3-sulfanylpropanoic acid
• (R)-3-Mercapto-2-(2-mercapto-2-methylpropanamido)propanoic acid
• <span class="text-smallcaps">L</span>-Cysteine, N-(2-mercapto-2-methyl-1-oxopropyl)-
• De 019
• N-(2-Mercapto-2-methyl-1-oxopropyl)-<span class="text-smallcaps">L</span>-cysteine
• N-(2-Mercapto-2-methylpropanoyl)-<span class="text-smallcaps">L</span>-cysteine
• N-(2-Mercapto-2-methylpropionyl)-<span class="text-smallcaps">L</span>-cysteine
• N-(2-Mercaptoisobutyryl)cysteine
• N-(2-methyl-2-sulfanylpropanoyl)-L-cysteine
• N-(2-methyl-2-sulfanylpropanoyl)cysteine
• Rimatil
• Sa 96
• Thiobutarit
• Tiobutarit

BUCILLAMINE

CAS: 65002-17-7

• Fórmula: C₇H₁₃NO₃S₂
• Pureza: 98%
• Forma y color: Solid
• Peso molecular: 223.3130

Bucillamine-d6

CAS: 65002-17-7

• Fórmula: C₇H₇D₆NO₃S₂
• Forma y color: White To Off-White Solid
• Peso molecular: 229.34

Bucillamine

CAS: 65002-17-7

• Fórmula: C₇H₁₃NO₃S₂
• Pureza: ≥ 95.0%
• Forma y color: White to off-white or pale yellow powder
• Peso molecular: 223.31

Bucillamine

CAS: 65002-17-7

• Fórmula: C₇H₁₃NO₃S₂
• Peso molecular: 223.31

Bucillamine

CAS: 65002-17-7

Stability Unstable in Solution, Air Sensitive Applications An antirheumatic agent. References Masutani, K., et al.: …

• Fórmula: C₇H₁₃NO₃S₂
• Forma y color: Neat
• Peso molecular: 223.31

Bucillamine

CAS: 65002-17-7

Potential treatment for gout and rheumatoid arthritis

• Fórmula: C₇H₁₃NO₃S₂
• Pureza: Min. 95 Area-%
• Forma y color: White Slightly Yellow Powder
• Peso molecular: 223.32 g/mol

Bucillamine

CAS: 65002-17-7

Bucillamine (DE019) protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of …

• Fórmula: C₇H₁₃NO₃S₂
• Pureza: 98.66%
• Forma y color: Solid
• Peso molecular: 223.31